The expanding demand for controlled immunological study and therapeutic development has spurred significant improvements in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently generated using various expression methods, including bacterial hosts, higher cell cultures, and ins